275 related articles for article (PubMed ID: 31129917)
1. Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial.
Schulz M; Griese-Mammen N; Anker SD; Koehler F; Ihle P; Ruckes C; Schumacher PM; Trenk D; Böhm M; Laufs U;
Eur J Heart Fail; 2019 Aug; 21(8):1012-1021. PubMed ID: 31129917
[TBL] [Abstract][Full Text] [Related]
2. PHARMacy-based interdisciplinary program for patients with Chronic Heart Failure (PHARM-CHF): rationale and design of a randomized controlled trial, and results of the pilot study.
Laufs U; Griese-Mammen N; Krueger K; Wachter A; Anker SD; Koehler F; Rettig-Ewen V; Botermann L; Strauch D; Trenk D; Böhm M; Schulz M
Eur J Heart Fail; 2018 Sep; 20(9):1350-1359. PubMed ID: 29846031
[TBL] [Abstract][Full Text] [Related]
3. Non-adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography-tandem mass spectrometry (results of a prospective multicentre study).
Gupta P; Voors AA; Patel P; Lane D; Anker SD; Cleland JGF; Dickstein K; Filippatos G; Lang CC; van Veldhuisen DJ; Metra M; Zannad F; Samani NJ; Jones DJL; Squire IB; Ng LL
Eur J Heart Fail; 2021 Jul; 23(7):1182-1190. PubMed ID: 33759308
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Adherence to Renin-Angiotensin System Inhibitors and β-Blockers After Heart Failure Hospitalization in Senior Patients.
Qin X; Hung J; Teng TK; Briffa T; Sanfilippo FM
J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):531-540. PubMed ID: 32500739
[TBL] [Abstract][Full Text] [Related]
5. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
[TBL] [Abstract][Full Text] [Related]
6. Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey.
Komajda M; Anker SD; Cowie MR; Filippatos GS; Mengelle B; Ponikowski P; Tavazzi L;
Eur J Heart Fail; 2016 May; 18(5):514-22. PubMed ID: 27095461
[TBL] [Abstract][Full Text] [Related]
7. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.
Güder G; Störk S; Gelbrich G; Brenner S; Deubner N; Morbach C; Wallenborn J; Berliner D; Ertl G; Angermann CE
Eur J Heart Fail; 2015 Apr; 17(4):442-52. PubMed ID: 25727879
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 18-Month Outcomes of Ambulatory Patients With Reduced (≤40%) Left Ventricular Ejection Fraction Treated in a Community-Based, Dedicated Heart Failure Clinic Versus Treated Elsewhere.
Murninkas D; Itzhaki Ben Zadok O; Iakobishvili Z; Jino H; Yohananov E; Birkenfeld S; Hasdai D
Am J Cardiol; 2019 Apr; 123(7):1101-1108. PubMed ID: 30658921
[TBL] [Abstract][Full Text] [Related]
9. Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study.
Majumdar SR; McAlister FA; Cree M; Chang WC; Packer M; Armstrong PW;
Clin Ther; 2004 May; 26(5):694-703. PubMed ID: 15220013
[TBL] [Abstract][Full Text] [Related]
10. Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial.
Solomon SD; Rizkala AR; Lefkowitz MP; Shi VC; Gong J; Anavekar N; Anker SD; Arango JL; Arenas JL; Atar D; Ben-Gal T; Boytsov SA; Chen CH; Chopra VK; Cleland J; Comin-Colet J; Duengen HD; Echeverría Correa LE; Filippatos G; Flammer AJ; Galinier M; Godoy A; Goncalvesova E; Janssens S; Katova T; Køber L; Lelonek M; Linssen G; Lund LH; O'Meara E; Merkely B; Milicic D; Oh BH; Perrone SV; Ranjith N; Saito Y; Saraiva JF; Shah S; Seferovic PM; Senni M; Sibulo AS; Sim D; Sweitzer NK; Taurio J; Vinereanu D; Vrtovec B; Widimský J; Yilmaz MB; Zhou J; Zweiker R; Anand IS; Ge J; Lam CSP; Maggioni AP; Martinez F; Packer M; Pfeffer MA; Pieske B; Redfield MM; Rouleau JL; Van Veldhuisen DJ; Zannad F; Zile MR; McMurray JJV
Circ Heart Fail; 2018 Jul; 11(7):e004962. PubMed ID: 29980595
[TBL] [Abstract][Full Text] [Related]
11. Directly Measured Adherence to Treatment in Chronic Heart Failure: LEVEL-CHF Registry.
Jelínek L; Václavík J; Ramík Z; Pavlů L; Benešová K; Jarkovský J; Lazárová M; Janečková H; Spurná J; Táborský M
Am J Med Sci; 2021 Apr; 361(4):491-498. PubMed ID: 33781390
[TBL] [Abstract][Full Text] [Related]
12. The impact of pharmacist/physician care on quality of life in elderly heart failure patients: results of the PHARM-CHF randomized controlled trial.
Schulz M; Griese-Mammen N; Schumacher PM; Anker SD; Koehler F; Ruckes C; Rettig-Ewen V; Wachter R; Trenk D; Böhm M; Laufs U
ESC Heart Fail; 2020 Dec; 7(6):3310-3319. PubMed ID: 32700409
[TBL] [Abstract][Full Text] [Related]
13. Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF.
Beusekamp JC; Tromp J; van der Wal HH; Anker SD; Cleland JG; Dickstein K; Filippatos G; van der Harst P; Hillege HL; Lang CC; Metra M; Ng LL; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zwinderman AH; Rossignol P; Zannad F; Voors AA; van der Meer P
Eur J Heart Fail; 2018 May; 20(5):923-930. PubMed ID: 29327797
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M
Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333
[TBL] [Abstract][Full Text] [Related]
15. Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.
Komajda M; Cowie MR; Tavazzi L; Ponikowski P; Anker SD; Filippatos GS;
Eur J Heart Fail; 2017 Nov; 19(11):1414-1423. PubMed ID: 28463464
[TBL] [Abstract][Full Text] [Related]
16. Impact of Individual Patient Profiles on Adherence to Guideline Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction: VCOR-HF Study.
Driscoll A; Dinh D; Wong J; Hopper I; Mariani J; Zimmet H; Brennan A; Lefkovits J; Carruthers H; Reid CM
Heart Lung Circ; 2020 Dec; 29(12):1782-1789. PubMed ID: 32646638
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
[TBL] [Abstract][Full Text] [Related]
18. Background Medical Therapy and Clinical Outcomes From the VICTORIA Trial.
Ezekowitz JA; McMullan CJ; Westerhout CM; Piña IL; Lopez-Sendon J; Anstrom KJ; Hernandez AF; Lam CSP; O'Connor CM; Pieske B; Ponikowski P; Roessig L; Voors AA; Koglin J; Armstrong PW; Butler J;
Circ Heart Fail; 2023 Sep; 16(9):e010599. PubMed ID: 37417824
[TBL] [Abstract][Full Text] [Related]
19. ESC guidelines adherence is associated with improved survival in patients from the Norwegian Heart Failure Registry.
De Blois J; Fagerland MW; Grundtvig M; Semb AG; Gullestad L; Westheim A; Hole T; Atar D; Agewall S
Eur Heart J Cardiovasc Pharmacother; 2015 Jan; 1(1):31-6. PubMed ID: 27533962
[TBL] [Abstract][Full Text] [Related]
20. Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial.
Sakata Y; Shiba N; Takahashi J; Miyata S; Nochioka K; Miura M; Takada T; Saga C; Shinozaki T; Sugi M; Nakagawa M; Sekiguchi N; Komaru T; Kato A; Fukuchi M; Nozaki E; Hiramoto T; Inoue K; Goto T; Ohe M; Tamaki K; Ibayashi S; Ishide N; Maruyama Y; Tsuji I; Shimokawa H; ;
Eur Heart J; 2015 Apr; 36(15):915-23. PubMed ID: 25637937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
